Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
19,800
Employees19,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
19,800
Employees19,800

EW Key Statistics

Market cap
53.72B
Market cap53.72B
Price-Earnings ratio
38.31
Price-Earnings ratio38.31
Dividend yield
Dividend yield
Average volume
2.35M
Average volume2.35M
High today
$90.47
High today$90.47
Low today
$88.58
Low today$88.58
Open price
$90.42
Open price$90.42
Volume
2.02M
Volume2.02M
52 Week high
$96.12
52 Week high$96.12
52 Week low
$60.57
52 Week low$60.57

EW News

Benzinga 2d
Edwards Lifesciences's Options: A Look at What the Big Money is Thinking - Edwards Lifesciences - Benzinga

Loading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Edwards Lifesciences. Looking at options history for Edwar...

Edwards Lifesciences's Options: A Look at What the Big Money is Thinking - Edwards Lifesciences - Benzinga
Benzinga 4d
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint

In this article: Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint On Monday, U.S. heart valve manufactur...

Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
TipRanks 4d
Edwards Lifesciences upgraded to Buy from Hold at Deutsche Bank

Deutsche Bank upgraded Edwards Lifesciences to Buy from Hold with a price target of $103, up from $86. The firm is increasingly confident in Edwards’ ability to...

Analyst ratings

59%

of 32 ratings
Buy
59.4%
Hold
34.4%
Sell
6.3%

More EW News

Simply Wall St 6d
Capital Investments At Edwards Lifesciences Point To A Promising Future - Simply Wall St

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll want to see a proven return on capital emp...

Capital Investments At Edwards Lifesciences Point To A Promising Future - Simply Wall St
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.